Quest Partners LLC Spring Works Therapeutics, Inc. Transaction History
Quest Partners LLC
- $737 Billion
- Q2 2024
A detailed history of Quest Partners LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2,440 shares of SWTX stock, worth $91,304. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,440
Previous 4,737
48.49%
Holding current value
$91,304
Previous $233 Million
60.58%
% of portfolio
0.01%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
221Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$245 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$210 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$138 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$135 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$128 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.34B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...